Galmed Pharmaceuticals
GLMD
#11038
Rank
A$7.47 M
Marketcap
A$7.00
Share price
21.05%
Change (1 day)
382.95%
Change (1 year)

EPS for Galmed Pharmaceuticals (GLMD)

EPS in 2026 (TTM): A-$19.18

According to Galmed Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$19.46. In 2017 the company made an earnings per share (EPS) of A-$2,132 an increase over its 2016 EPS that were of A-$3,242.

EPS history for Galmed Pharmaceuticals from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$19.18
2017A-$2,132-34.23%
2016A-$3,24256.84%
2015A-$2,067

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Evoke Pharma
EVOK
A-$3.81-80.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
A-$1.62-91.69%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
A-$1.13-94.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
A-$9.56-50.85%๐Ÿ‡บ๐Ÿ‡ธ USA